Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- Author
- VERMEIRE, Severine1 ; O'BYRNE, Sharon2 ; BAUMGART, Daniel C8 ; SCHREIBER, Stefan9 ; DOTAN, Iris10 11 ; SANDBORN, William J3 ; TEW, Gaik W2 ; LUCA, Diana2 ; TANG, Meina T2 ; DIEHL, Lauri2 ; EASTHAM-ANDERSON, Jeffrey2 ; DE HERTOGH, Gert1 ; KEIR, Mary2 ; PERRIER, Clementine1 ; EGEN, Jackson G2 ; KIRBY, John A4 ; VAN ASSCHE, Gert1 6 ; RUTGEERTS, Paul1 ; WILLIAMS, Marna2 ; LU, Timothy T2 ; MANSFIELD, John C4 ; LAMB, Christopher A4 ; FEAGAN, Brian G5 ; PANES, Julian7 ; SALAS, Azucena7
[1] University of Leuven, Leuven, Belgium
[2] Research and Early Development, Genentech, South San Francisco, CA, United States
[3] University of California San Diego, La Jolla, CA, United States
[4] University of Newcastle, Newcastle upon Tyne, United Kingdom
[5] University of Western Ontario, London, ON, Canada
[6] University of Toronto, Toronto, ON, Canada
[7] Hospital Clinic de Barcelona, Barcelona, Spain
[8] Charité Medical School, Humboldt-University of Berlin, Berlin, Germany
[9] Christian Albrechts University, Kiel, Germany
[10] Tel Aviv Medical Centre, Tel Aviv, Israel
[11] Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel - Source
Lancet (British edition). 2014, Vol 384, Num 9940, pp 309-318, 10 p ; ref : 29 ref
- CODEN
- LANCAO
- ISSN
- 0140-6736
- Scientific domain
- General medicine general surgery
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Chimiothérapie Essai clinique phase II Essai clinique Médecine Rectocolite ulcérohémorragique Traitement induction Essai randomisé contrôlé Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin Traitement
- Keyword (en)
- Chemotherapy Phase II trial Clinical trial Medicine Ulcerative colitis Induction treatment Randomized controlled trial Inflammatory disease Digestive diseases Intestinal disease Treatment
- Keyword (es)
- Quimioterapia Ensayo clínico fase II Ensayo clínico Medicina Rectocolitis ulcerohemorrágica Tratamiento inductivo Ensayo aleatorio controlado Enfermedad inflamatoria Aparato digestivo patología Intestino patología Tratamiento
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B03 Other diseases. Semiology
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28691035
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S0140-6736(14)60661-9 
https://dx.doi.org/10.1016/S0140-6736(14)60661-9
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(14)60661-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"384\";s:8:\"\u0000*\u0000issue\";s:4:\"9940\";s:8:\"\u0000*\u0000spage\";s:3:\"309\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"VERMEIRE\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Severine\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:15:\"O'BYRNE, Sharon\";i:1;s:18:\"BAUMGART, Daniel C\";i:2;s:17:\"SCHREIBER, Stefan\";i:3;s:11:\"DOTAN, Iris\";i:4;s:19:\"SANDBORN, William J\";i:5;s:11:\"TEW, Gaik W\";i:6;s:11:\"LUCA, Diana\";i:7;s:13:\"TANG, Meina T\";i:8;s:12:\"DIEHL, Lauri\";i:9;s:25:\"EASTHAM-ANDERSON, Jeffrey\";i:10;s:16:\"DE HERTOGH, Gert\";i:11;s:10:\"KEIR, Mary\";i:12;s:19:\"PERRIER, Clementine\";i:13;s:15:\"EGEN, Jackson G\";i:14;s:13:\"KIRBY, John A\";i:15;s:16:\"VAN ASSCHE, Gert\";i:16;s:15:\"RUTGEERTS, Paul\";i:17;s:15:\"WILLIAMS, Marna\";i:18;s:13:\"LU, Timothy T\";i:19;s:17:\"MANSFIELD, John C\";i:20;s:19:\"LAMB, Christopher A\";i:21;s:15:\"FEAGAN, Brian G\";i:22;s:13:\"PANES, Julian\";i:23;s:14:\"SALAS, Azucena\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(14)60661-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"384\";s:8:\"\u0000*\u0000issue\";s:4:\"9940\";s:8:\"\u0000*\u0000spage\";s:3:\"309\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"VERMEIRE\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Severine\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:15:\"O'BYRNE, Sharon\";i:1;s:18:\"BAUMGART, Daniel C\";i:2;s:17:\"SCHREIBER, Stefan\";i:3;s:11:\"DOTAN, Iris\";i:4;s:19:\"SANDBORN, William J\";i:5;s:11:\"TEW, Gaik W\";i:6;s:11:\"LUCA, Diana\";i:7;s:13:\"TANG, Meina T\";i:8;s:12:\"DIEHL, Lauri\";i:9;s:25:\"EASTHAM-ANDERSON, Jeffrey\";i:10;s:16:\"DE HERTOGH, Gert\";i:11;s:10:\"KEIR, Mary\";i:12;s:19:\"PERRIER, Clementine\";i:13;s:15:\"EGEN, Jackson G\";i:14;s:13:\"KIRBY, John A\";i:15;s:16:\"VAN ASSCHE, Gert\";i:16;s:15:\"RUTGEERTS, Paul\";i:17;s:15:\"WILLIAMS, Marna\";i:18;s:13:\"LU, Timothy T\";i:19;s:17:\"MANSFIELD, John C\";i:20;s:19:\"LAMB, Christopher A\";i:21;s:15:\"FEAGAN, Brian G\";i:22;s:13:\"PANES, Julian\";i:23;s:14:\"SALAS, Azucena\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(14)60661-9\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(14)60661-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"384\";s:8:\"\u0000*\u0000issue\";s:4:\"9940\";s:8:\"\u0000*\u0000spage\";s:3:\"309\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"VERMEIRE\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Severine\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:15:\"O'BYRNE, Sharon\";i:1;s:18:\"BAUMGART, Daniel C\";i:2;s:17:\"SCHREIBER, Stefan\";i:3;s:11:\"DOTAN, Iris\";i:4;s:19:\"SANDBORN, William J\";i:5;s:11:\"TEW, Gaik W\";i:6;s:11:\"LUCA, Diana\";i:7;s:13:\"TANG, Meina T\";i:8;s:12:\"DIEHL, Lauri\";i:9;s:25:\"EASTHAM-ANDERSON, Jeffrey\";i:10;s:16:\"DE HERTOGH, Gert\";i:11;s:10:\"KEIR, Mary\";i:12;s:19:\"PERRIER, Clementine\";i:13;s:15:\"EGEN, Jackson G\";i:14;s:13:\"KIRBY, John A\";i:15;s:16:\"VAN ASSCHE, Gert\";i:16;s:15:\"RUTGEERTS, Paul\";i:17;s:15:\"WILLIAMS, Marna\";i:18;s:13:\"LU, Timothy T\";i:19;s:17:\"MANSFIELD, John C\";i:20;s:19:\"LAMB, Christopher A\";i:21;s:15:\"FEAGAN, Brian G\";i:22;s:13:\"PANES, Julian\";i:23;s:14:\"SALAS, Azucena\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(14)60661-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"384\";s:8:\"\u0000*\u0000issue\";s:4:\"9940\";s:8:\"\u0000*\u0000spage\";s:3:\"309\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"VERMEIRE\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Severine\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:15:\"O'BYRNE, Sharon\";i:1;s:18:\"BAUMGART, Daniel C\";i:2;s:17:\"SCHREIBER, Stefan\";i:3;s:11:\"DOTAN, Iris\";i:4;s:19:\"SANDBORN, William J\";i:5;s:11:\"TEW, Gaik W\";i:6;s:11:\"LUCA, Diana\";i:7;s:13:\"TANG, Meina T\";i:8;s:12:\"DIEHL, Lauri\";i:9;s:25:\"EASTHAM-ANDERSON, Jeffrey\";i:10;s:16:\"DE HERTOGH, Gert\";i:11;s:10:\"KEIR, Mary\";i:12;s:19:\"PERRIER, Clementine\";i:13;s:15:\"EGEN, Jackson G\";i:14;s:13:\"KIRBY, John A\";i:15;s:16:\"VAN ASSCHE, Gert\";i:16;s:15:\"RUTGEERTS, Paul\";i:17;s:15:\"WILLIAMS, Marna\";i:18;s:13:\"LU, Timothy T\";i:19;s:17:\"MANSFIELD, John C\";i:20;s:19:\"LAMB, Christopher A\";i:21;s:15:\"FEAGAN, Brian G\";i:22;s:13:\"PANES, Julian\";i:23;s:14:\"SALAS, Azucena\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0140-6736(14)60661-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"384\";s:8:\"\u0000*\u0000issue\";s:4:\"9940\";s:8:\"\u0000*\u0000spage\";s:3:\"309\";s:8:\"\u0000*\u0000epage\";s:3:\"318\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"VERMEIRE\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Severine\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:24:{i:0;s:15:\"O'BYRNE, Sharon\";i:1;s:18:\"BAUMGART, Daniel C\";i:2;s:17:\"SCHREIBER, Stefan\";i:3;s:11:\"DOTAN, Iris\";i:4;s:19:\"SANDBORN, William J\";i:5;s:11:\"TEW, Gaik W\";i:6;s:11:\"LUCA, Diana\";i:7;s:13:\"TANG, Meina T\";i:8;s:12:\"DIEHL, Lauri\";i:9;s:25:\"EASTHAM-ANDERSON, Jeffrey\";i:10;s:16:\"DE HERTOGH, Gert\";i:11;s:10:\"KEIR, Mary\";i:12;s:19:\"PERRIER, Clementine\";i:13;s:15:\"EGEN, Jackson G\";i:14;s:13:\"KIRBY, John A\";i:15;s:16:\"VAN ASSCHE, Gert\";i:16;s:15:\"RUTGEERTS, Paul\";i:17;s:15:\"WILLIAMS, Marna\";i:18;s:13:\"LU, Timothy T\";i:19;s:17:\"MANSFIELD, John C\";i:20;s:19:\"LAMB, Christopher A\";i:21;s:15:\"FEAGAN, Brian G\";i:22;s:13:\"PANES, Julian\";i:23;s:14:\"SALAS, Azucena\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:96:\"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
